help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on February 12, 2009, doi:10.1164/rccm.200807-1089OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200807-1089OCv1
179/9/799    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelsen, S. G.
Right arrow Articles by Kim, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelsen, S. G.
Right arrow Articles by Kim, V.
American Journal of Respiratory and Critical Care Medicine Vol 179. pp. 799-805, (2009)
© 2009 American Thoracic Society
doi: 10.1164/rccm.200807-1089OC


Original Article

Lymphoid Follicle Cells in Chronic Obstructive Pulmonary Disease Overexpress the Chemokine Receptor CXCR3

Steven G. Kelsen1, Mark O. Aksoy1, Mary Georgy1, Richard Hershman1, Rong Ji1, XiuXia Li1, Matthew Hurford2, Charalambos Solomides2, Wissam Chatila1 and Victor Kim1

1 Department of Medicine and 2 Department of Pathology, Temple University School of Medicine, Philadelphia, Pennsylvania

Correspondence and requests for reprints should be addressed to Steven G. Kelsen, M.D., 761 Parkinson Pavilion, Temple University Hospital, 3401 N. Broad St., Philadelphia, PA 19140. E-mail: kelsen{at}temple.edu.

Rationale: The mechanisms underlying formation of lung lymphoid follicles (LF) in chronic obstructive pulmonary disease (COPD) are unknown. The chemokine receptor CXCR3 regulates immune responses in secondary lymphoid structures elsewhere in the body and is highly expressed by Th1 lymphocytes in the airway in COPD. Because chemokine receptors control inflammatory cell homing to inflamed tissue, we reasoned that CXCR3 may contribute to LF formation in COPD.

Objectives: We assessed the expression of CXCR3 and its ligands (IP-10/CXCL10, Mig/CXCL9, and ITAC/CXCL11) by LF cells in never-smokers, smokers without COPD, and subjects with COPD.

Methods: CXCR3, IP-10, Mig, and ITAC expression were assessed in lung sections from 46 subjects (never-smokers, smokers without COPD [S], and subjects with COPD in GOLD stages 1–4) by immunohistochemistry.

Measurements and Main Results: CXCR3-expressing T cells (CD8+ or CD4+) and B cells (CD20+) were topographically distributed at the follicle periphery and center, respectively. The percentage of immunohistochemically identified CXCR3+ cells increased progressively while proceeding from S through GOLD 3–4 (P < 0.01 for GOLD 3–4 vs. S). Moreover, the number of CXCR3+ follicular cells correlated inversely with FEV1 (r = 0.60). The CXCR3 ligands IP-10 and Mig were expressed by several cell types in and around the follicle, including CD68+ dendritic cells/ macrophages, airway epithelial cells, endothelial cells, and T and B cells.

Conclusions: These results suggest that LF form in the COPD lung by recruitment and/or retention of CXCR3-expressing T and B lymphocytes, which are attracted to the region through production of CXCR3 ligands IP-10 and Mig by lung structural and follicular cells.

Key Words: lung inflammation • chemokines • cell recruitment


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
The chemokine receptor CXCR3 regulates immune responses in secondary lymphoid structures and is highly expressed by Th1 lymphocytes in the airway in chronic obstructive pulmonary disease (COPD). In contrast, the mechanisms underlying formation of lung lymphoid follicles in COPD are unknown.

What This Study Adds to the Field
We report that the chemokine receptor CXCR3 and its ligands Mig/CXCL9 and IP-10/CXCL10 are highly expressed by cells in and around lymphoid follicles in COPD. These findings suggest that CXCR3 contributes to follicle formation in COPD.

 



This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
P. J. Barnes
The Cytokine Network in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Cell Mol. Biol., December 1, 2009; 41(6): 631 - 638.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2009 American Thoracic Society
  Membership Renewal